HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides mutual fund investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is headquartered in Draper, Utah.
IPO Year: 2014
Exchange: NASDAQ
Website: healthequity.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/15/2024 | $108.00 | Neutral | Goldman |
| 4/4/2024 | $101.00 | Mkt Outperform | JMP Securities |
| 4/2/2024 | $86.00 → $108.00 | Overweight | JP Morgan |
| 1/3/2024 | $84.00 | Overweight | Barclays |
| 9/21/2023 | $79.00 → $87.00 | Neutral → Outperform | Robert W. Baird |
| 10/21/2022 | $64.00 → $77.00 | Sell → Neutral | Goldman |
| 9/16/2022 | $85.00 | Overweight | KeyBanc Capital Markets |
| 7/12/2022 | $59.00 | Sell | Goldman |
| 4/11/2022 | $95.00 | Overweight | Wells Fargo |
| 4/7/2022 | $89.00 | Buy | Guggenheim |
SC 13G/A - HEALTHEQUITY, INC. (0001428336) (Subject)
SC 13G/A - HEALTHEQUITY, INC. (0001428336) (Subject)
SC 13G/A - HEALTHEQUITY, INC. (0001428336) (Subject)
SC 13G/A - HEALTHEQUITY, INC. (0001428336) (Subject)
SC 13G/A - HEALTHEQUITY, INC. (0001428336) (Subject)
SC 13G - HEALTHEQUITY, INC. (0001428336) (Subject)
SC 13G/A - HEALTHEQUITY, INC. (0001428336) (Subject)
SC 13G/A - HEALTHEQUITY, INC. (0001428336) (Subject)
SC 13G/A - HEALTHEQUITY, INC. (0001428336) (Subject)
SC 13G/A - HEALTHEQUITY, INC. (0001428336) (Subject)
8-K - HEALTHEQUITY, INC. (0001428336) (Filer)
144 - HEALTHEQUITY, INC. (0001428336) (Subject)
S-3ASR - HEALTHEQUITY, INC. (0001428336) (Filer)
10-Q - HEALTHEQUITY, INC. (0001428336) (Filer)
8-K - HEALTHEQUITY, INC. (0001428336) (Filer)
8-K - HEALTHEQUITY, INC. (0001428336) (Filer)
S-8 POS - HEALTHEQUITY, INC. (0001428336) (Filer)
S-8 POS - HEALTHEQUITY, INC. (0001428336) (Filer)
S-8 POS - HEALTHEQUITY, INC. (0001428336) (Filer)
S-8 POS - HEALTHEQUITY, INC. (0001428336) (Filer)
4 - HEALTHEQUITY, INC. (0001428336) (Issuer)
4 - HEALTHEQUITY, INC. (0001428336) (Issuer)
4 - HEALTHEQUITY, INC. (0001428336) (Issuer)
4 - HEALTHEQUITY, INC. (0001428336) (Issuer)
4 - HEALTHEQUITY, INC. (0001428336) (Issuer)
4 - HEALTHEQUITY, INC. (0001428336) (Issuer)
4 - HEALTHEQUITY, INC. (0001428336) (Issuer)
4 - HEALTHEQUITY, INC. (0001428336) (Issuer)
4 - HEALTHEQUITY, INC. (0001428336) (Issuer)
4 - HEALTHEQUITY, INC. (0001428336) (Issuer)
DRAPER, Utah, Nov. 19, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY), a leader in health savings accounts (HSAs) and consumer-directed benefits, is proud to announce Chief Marketing Officer Tia Padia has been recognized with the MarCom Visionary CMO Award for her innovative leadership in the category of Individual's Body of Work. This award recognizes Padia's creative vision to develop the HealthEquity Immersion Experience — a project that showcases HealthEquity's deep understanding of the client and member benefits journey through an interactive, immersive event. "This award goes beyond individual recognition, it's a reflection of the tremendous commitment we have at HealthEq
DRAPER, Utah, Nov. 12, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity" or the "Company"), the nation's largest health savings account ("HSA") custodian, today announced that after leading the company for more than 15 years, Jon Kessler, President and Chief Executive Officer, has decided to retire effective January 6, 2025. Mr. Kessler will remain a director and act a special advisor to the Company through April 30, 2025. To succeed Mr. Kessler, the Company announced the appointment of Scott Cutler, who will join HealthEquity as President and CEO and as a director effective January 6, 2025. HealthEquity management will host a conference call for investors on Tues
DRAPER, Utah, Oct. 30, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity" or the "Company"), the nation's largest health savings account ("HSA") custodian, today announced plans to release its third quarter of fiscal 2025 financial results following the close of regular stock market trading hours on Monday, December 9, 2024. Following the news release, HealthEquity management plans to host a conference call for investors on Monday, December 9, 2024, at 4:30 p.m. Eastern Time during which management will review the Company's third quarter results. HealthEquity Third Quarter Fiscal Year 2025 Results Conference CallDate:December 9, 2024Time:4:30 p.m. Eastern Time / 2:30
DRAPER, Utah, Oct. 24, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity"), the leader in health savings accounts (HSAs) and consumer-directed benefits administration, has earned two Golden Globee® awards at the 2024 Globee® Awards for Technology, including the Golden Globee® for Achievement in Leadership of Technology Strategy and Chief Technology Officer of the Year honors for Executive Vice President and Chief Technology Officer, Eli Rosner. Both awards noted HealthEquity's early leadership in deployment of real-world applications of AI. "Our teammates believe innovation can serve our mission to save and improve lives by empowering healthcare consumers," said Ro
DRAPER, Utah, Oct. 15, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity") in celebration of National HSA Awareness Day, has launched HSAnswers. Powered by a comprehensive and bespoke database of resources, research, and insights, the free-to-use AI chat tool can help individuals obtain clear answers to questions about HSAs and other consumer-directed benefits. In 2024 HealthEquity surveyed over 600 employees who said their top benefits challenge was being overwhelmed by the amount of information available to them. HSAnswers helps provide the extra support employees are asking for by serving up the answer for them without them having to dig through a mountain of in
DRAPER, Utah, Sept. 26, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity") today released research findings on how Health Savings Account (HSA) contribution strategies influence how employees participate in their HSA benefits. The qualitative and quantitative analysis included a sample of nearly 2,000 HealthEquity clients and more than 2 million HSA members. The analysis provides insight for employers who want to create impactful HSA benefit strategies that support their employees' financial wellbeing. "Benefit leaders want employees to get the most out of their benefits — including HSAs — and fostering utilization is a constant challenge," said Amanda Riley, he
Highlights of the second quarter include: Revenue of $299.9 million, an increase of 23% compared to $243.5 million in Q2 FY24.Net income of $35.8 million, compared to $10.6 million in Q2 FY24, with non-GAAP net income of $76.3 million, an increase of 67% compared to $45.6 million in Q2 FY24.Net income per diluted share of $0.40, compared to $0.12 in Q2 FY24, with non-GAAP net income per diluted share of $0.86, compared to $0.53 in Q2 FY24.Adjusted EBITDA of $128.3 million, an increase of 46% compared to $88.1 million in Q2 FY24.9.4 million HSAs, an increase of 15% compared to Q2 FY24.Total HSA Assets of $29.5 billion, an increase of 27% compared to Q2 FY24.16.3 million Total Accounts,
DRAPER, Utah, Sept. 03, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY), the nation's largest Health Savings Account ("HSA") custodian, today announced a new collaboration with Paytient, a healthcare technology firm, to offer employees greater confidence pursuing healthcare through Health Payment Accounts (HPAs). Forty percent of workplace-insured Americans reported deferring care due to cost.1 With HPAs, employers can offer employees and their families the option to better manage copays over time for medical, dental, vision, Rx and behavioral care—it even works for pet care at the vet. This safety net improves access to essential care, eliminates the hassle and embarrassment of
DRAPER, Utah, Aug. 21, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity"), the leader in health savings accounts (HSAs) and consumer-directed benefits administration, will kick off the second annual HSA WeekTM on August 26. The weeklong event will include a variety of resources to educate workers and companies about HSAs and their potential to improve healthcare savings and financial stability. According to a recent HealthEquity research study, roughly 40% of employees lack confidence in their health plan decisions and more than half wonder at times if they have chosen the right plan for their needs. The good news is that education can help. The study also found th
DRAPER, Utah, Aug. 13, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity" or the "Company"), the nation's largest health savings account ("HSA") custodian, today announced plans to release its second quarter of fiscal 2025 financial results following the close of regular stock market trading hours on Tuesday, September 3, 2024. Following the news release, HealthEquity management plans to host a conference call for investors on Tuesday, September 3, 2024, at 4:30 p.m. Eastern Time during which management will review the Company's second quarter results. HealthEquity Second Quarter Fiscal Year 2025 Results Conference CallDate:September 3, 2024Time:4:30 p.m. Eastern Time
DRAPER, Utah, Nov. 12, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity" or the "Company"), the nation's largest health savings account ("HSA") custodian, today announced that after leading the company for more than 15 years, Jon Kessler, President and Chief Executive Officer, has decided to retire effective January 6, 2025. Mr. Kessler will remain a director and act a special advisor to the Company through April 30, 2025. To succeed Mr. Kessler, the Company announced the appointment of Scott Cutler, who will join HealthEquity as President and CEO and as a director effective January 6, 2025. HealthEquity management will host a conference call for investors on Tues
DRAPER, Utah, Oct. 30, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity" or the "Company"), the nation's largest health savings account ("HSA") custodian, today announced plans to release its third quarter of fiscal 2025 financial results following the close of regular stock market trading hours on Monday, December 9, 2024. Following the news release, HealthEquity management plans to host a conference call for investors on Monday, December 9, 2024, at 4:30 p.m. Eastern Time during which management will review the Company's third quarter results. HealthEquity Third Quarter Fiscal Year 2025 Results Conference CallDate:December 9, 2024Time:4:30 p.m. Eastern Time / 2:30
Highlights of the second quarter include: Revenue of $299.9 million, an increase of 23% compared to $243.5 million in Q2 FY24.Net income of $35.8 million, compared to $10.6 million in Q2 FY24, with non-GAAP net income of $76.3 million, an increase of 67% compared to $45.6 million in Q2 FY24.Net income per diluted share of $0.40, compared to $0.12 in Q2 FY24, with non-GAAP net income per diluted share of $0.86, compared to $0.53 in Q2 FY24.Adjusted EBITDA of $128.3 million, an increase of 46% compared to $88.1 million in Q2 FY24.9.4 million HSAs, an increase of 15% compared to Q2 FY24.Total HSA Assets of $29.5 billion, an increase of 27% compared to Q2 FY24.16.3 million Total Accounts,
DRAPER, Utah, Aug. 13, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity" or the "Company"), the nation's largest health savings account ("HSA") custodian, today announced plans to release its second quarter of fiscal 2025 financial results following the close of regular stock market trading hours on Tuesday, September 3, 2024. Following the news release, HealthEquity management plans to host a conference call for investors on Tuesday, September 3, 2024, at 4:30 p.m. Eastern Time during which management will review the Company's second quarter results. HealthEquity Second Quarter Fiscal Year 2025 Results Conference CallDate:September 3, 2024Time:4:30 p.m. Eastern Time
Highlights of the first quarter include: Revenue of $287.6 million, an increase of 18% compared to $244.4 million in Q1 FY24.Net income of $28.8 million, compared to $4.1 million in Q1 FY24, with non-GAAP net income of $70.3 million, an increase of 64% compared to $42.8 million in Q1 FY24.Net income per diluted share of $0.33, compared to $0.05 in Q1 FY24, with non-GAAP net income per diluted share of $0.80, compared to $0.50 in Q1 FY24.Adjusted EBITDA of $117.4 million, an increase of 36% compared to $86.6 million in Q1 FY24.9.1 million HSAs, an increase of 13% compared to Q1 FY24.Total HSA Assets of $27.3 billion, an increase of 22% compared to Q1 FY24.16.0 million Total Accounts, i
DRAPER, Utah, May 07, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity" or the "Company"), the nation's largest health savings account ("HSA") custodian, today announced plans to release its first quarter of fiscal 2025 financial results following the close of regular stock market trading hours on Monday, June 3, 2024. Following the news release, HealthEquity management plans to host a conference call for investors on Monday, June 3, 2024, at 4:30 p.m. Eastern Time during which management will review the Company's first quarter results. HealthEquity First Quarter Fiscal Year 2025 Results Conference CallDate:June 3, 2024Time:4:30 p.m. Eastern Time / 2:30 p.m. Moun
Highlights of the fiscal year include: Revenue of $999.6 million, an increase of 16% compared to $861.7 million in FY23.Net income of $55.7 million, compared to net loss of $26.1 million in FY23, with non-GAAP net income of $195.5 million, compared to $114.5 million in FY23.Net income per diluted share of $0.64, compared to net loss per diluted share of $0.31 in FY23, with non-GAAP net income per diluted share of $2.25, compared to $1.36 in FY23.Adjusted EBITDA of $369.2 million, an increase of 36% compared to $272.3 million in FY23.8.7 million HSAs, an increase of 9% compared to FY23.Total HSA Assets of $25.2 billion, an increase of 14% compared to FY23.15.7 million Total Accounts, includi
DRAPER, Utah, March 05, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity" or the "Company"), the nation's largest health savings account ("HSA") custodian, today announced plans to release its fourth quarter and fiscal year end 2024 financial results following the close of regular stock market trading hours on Tuesday, March 19, 2024. Following the news release, HealthEquity management plans to host a conference call for investors on Tuesday, March 19, 2024, at 4:30 p.m. ET during which management will review the Company's financial results. HealthEquity Fourth Quarter and Fiscal Year End 2024 Results Conference Call Date:March 19, 2024Time:4:30 p.m. East
Highlights of the third quarter include: Revenue of $249.2 million, an increase of 15% compared to $216.1 million in Q3 FY23.Net income of $14.7 million, compared to net loss of $1.6 million in Q3 FY23, with non-GAAP net income of $52.2 million, an increase of 61% compared to $32.4 million in Q3 FY23.Net income per diluted share of $0.17, compared to net loss per diluted share of $0.02 in Q3 FY23, with non-GAAP net income per diluted share of $0.60, compared to $0.38 in Q3 FY23.Adjusted EBITDA of $95.6 million, an increase of 30% compared to $73.4 million in Q3 FY23.8.3 million HSAs, an increase of 8% compared to Q3 FY23.Total HSA Assets of $22.6 billion, an increase of 12% compared to Q3 F
DRAPER, Utah , Nov. 08, 2023 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity" or the "Company"), the nation's largest health savings account ("HSA") custodian, today announced plans to release its third quarter of fiscal 2024 financial results following the close of regular stock market trading hours on Tuesday, December 5, 2023. Following the news release, HealthEquity management plans to host a conference call for investors on Tuesday, December 5, 2023, at 4:30 p.m. ET during which management will review the Company's third quarter results. HealthEquity Third Quarter Fiscal Year 2024 Results Conference Call Date:December 5, 2023Time:4:30 p.m. Eastern Time / 2:30 p.m.
DRAPER, Utah, Aug. 21, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity"), the leader in health savings accounts (HSAs) and consumer-directed benefits administration, will kick off the second annual HSA WeekTM on August 26. The weeklong event will include a variety of resources to educate workers and companies about HSAs and their potential to improve healthcare savings and financial stability. According to a recent HealthEquity research study, roughly 40% of employees lack confidence in their health plan decisions and more than half wonder at times if they have chosen the right plan for their needs. The good news is that education can help. The study also found th
PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company") announced today that Evelyn Dilsaver has been appointed to serve as a member of its Board of Directors. "We're thrilled to have Evelyn join our board," said Jason Murray, PACS Chairman and CEO. "She has great experience as an accounting and finance professional, not to mention her work on the boards of several other public companies. She'll bring added perspective and expertise to the board as we work to guide PACS going forward." "I'm excited to join the PACS Board and assist the company in continuing its mission to provide quality skilled nursing care. I look forward to great things ahead for the company," added Ms. Dilsaver. Ms.
Healthcare IT Industry Expert Will Support the Firm's HCIT Strategy Thomas H. Lee Partners, L.P. ("THL"), a premier private equity firm investing in middle-market growth companies, today announced the appointment of Paul Black as a consultant for the firm's healthcare investment group. Black, who brings more than 25 years of experience leading companies in healthcare information technology ("Healthcare IT"), will support the team's efforts in identifying, sourcing, and growing investment opportunities across the healthcare market. "We are very pleased to welcome Paul to THL as a consultant for the firm's healthcare group," said Shahab Vagefi, Managing Director at THL. "THL has had a longs
Goldman initiated coverage of HealthEquity with a rating of Neutral and set a new price target of $108.00
JMP Securities initiated coverage of HealthEquity with a rating of Mkt Outperform and set a new price target of $101.00
JP Morgan reiterated coverage of HealthEquity with a rating of Overweight and set a new price target of $108.00 from $86.00 previously
Barclays initiated coverage of HealthEquity with a rating of Overweight and set a new price target of $84.00
Robert W. Baird upgraded HealthEquity from Neutral to Outperform and set a new price target of $87.00 from $79.00 previously
Goldman upgraded HealthEquity from Sell to Neutral and set a new price target of $77.00 from $64.00 previously
KeyBanc Capital Markets initiated coverage of HealthEquity with a rating of Overweight and set a new price target of $85.00
Goldman initiated coverage of HealthEquity with a rating of Sell and set a new price target of $59.00
Wells Fargo initiated coverage of HealthEquity with a rating of Overweight and set a new price target of $95.00
Guggenheim initiated coverage of HealthEquity with a rating of Buy and set a new price target of $89.00
HealthEquity (NASDAQ:HQY) has outperformed the market over the past 10 years by 4.88% on an annualized basis producing an average annual return of 15.82%. Currently, HealthEquity has a market capitalization of $6.56 billion. Buying $100 In HQY: If an investor had bought $100 of HQY stock 10 years ago, it would be worth $434.18 today based on a price of $75.44 for HQY at the time of writing. HealthEquity's Performance Over Last 10 Years Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time. This article was generated by Benzinga's automated content engine a
HealthEquity (NASDAQ:HQY) has outperformed the market over the past 10 years by 4.89% on an annualized basis producing an average annual return of 15.9%. Currently, HealthEquity has a market capitalization of $6.66 billion. Buying $100 In HQY: If an investor had bought $100 of HQY stock 10 years ago, it would be worth $437.38 today based on a price of $76.49 for HQY at the time of writing. HealthEquity's Performance Over Last 10 Years Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time. This article was generated by Benzinga's automated content engine an
HealthEquity's (NYSE:HQY) short percent of float has risen 4.55% since its last report. The company recently reported that it has 3.43 million shares sold short, which is 4.6% of all regular shares that are available for trading. Based on its trading volume, it would take traders 5.85 days to cover their short positions on average. Why Short Interest Matters Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises. Short interest is
B of A Securities analyst Allen Lutz maintains HealthEquity (NASDAQ:HQY) with a Buy and maintains $105 price target.
HealthEquity (NASDAQ:HQY) has been analyzed by 11 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 10 0 0 0 Last 30D 0 1 0 0 0 1M Ago 1 7 0 0 0 2M Ago 0 0 0 0 0 3M Ago 0 2 0 0 0 The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $103.82, a high estimate of $110.00, and a low estimate of $92.00. This current average has i
Wells Fargo analyst Stan Berenshteyn maintains HealthEquity (NASDAQ:HQY) with a Overweight and raises the price target from $107 to $110.
Raymond James analyst C. Gregory Peters maintains HealthEquity (NASDAQ:HQY) with a Outperform and raises the price target from $100 to $105.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Keybanc raised the price target for HealthEquity, Inc. (NASDAQ:HQY) from $95 to $100. Keybanc analyst Scott Schoenhaus maintained an Overweight rating. HealthEquity shares gained 2.7% to close at $83.40 on Tuesday. See how other analysts view this stock. HC Wainwright & Co. boosted the price target for HOOKIPA Pharma Inc. (NASDAQ:HOOK) from $5 to $6. HC Wainwright & Co. analyst Arthur He maintained a Buy rating. HOOKIPA Pharma shares fell 8.1% to close at $0.7990 on Tuesday. See how other analysts
Keybanc analyst Scott Schoenhaus maintains HealthEquity (NASDAQ:HQY) with a Overweight and raises the price target from $95 to $100.
Ratings for HealthEquity (NASDAQ:HQY) were provided by 13 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 3 10 0 0 0 Last 30D 1 5 0 0 0 1M Ago 0 0 0 0 0 2M Ago 0 0 0 0 0 3M Ago 2 5 0 0 0 The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $101.62, a high estimate of $110.00, and a low est